Half of patients were considered as affected by a severe disease and exhibited more commonly respiratory disorders, neutropenia, and high CRP level and needed more transfusion and longer duration of antibiotics and length of stay compared to the patients with non-severe IGASI. The gene discussed is CRP; the disease is neutropenia.